Assessment of concerns about vaccination among recovered COVID-19 patients in Saudi Arabia
East. Mediterr. health j
; 29(4): 276-284, 2023-04.
Article
in English
| WHOLIS, WHOIRIS | ID: covidwho-2321560
Responsible library:
CH1.1
ABSTRACT
Background:
Vaccine hesitancy re-emerged as a critical public health issue during the COVID-19 pandemic.Aims:
This study assessed the concerns of recovered COVID-19 patients about vaccination and the predictors of vaccine hesitancy.Methods:
This was a cross-sectional study of 319 adult patients who recovered from COVID-19 in Saudi Arabia. It was conducted during 1 May to 1 October 2020 at King Abdulaziz Medical City, Riyadh. Each participant was interviewed 6–12 months post-recovery using the vaccination attitude examination scale. Data were collected on COVID-19 illness severity, sociodemographic characteristics, history of chronic disease, and post-COVID-19 vaccination. Level of vaccination concern was assessed based on the percentage mean score (PMS).Results:
Most (85.3%) of the patients who recovered from COVID-19 expressed moderate overall concern (PMS = 68.96%) about vaccination. Concern was highest for mistrust in vaccine benefits (PMS = 90.28%), followed by natural immunity preference (PMS = 81.33%) and worries about the vaccine side-effects (PMS = 60.29%). Concern over commercial profiteering was low (PMS = 43.92%). The overall PMS for concern about vaccination was significantly higher among patients aged 45+ years (t = 3.12, P = 0.002) and among those who had experienced severe COVID-19 illness (t = 1.96, P = 0.05).Conclusion:
Overall concern about vaccination was high, and specific concerns were prevalent. Patient education on how the vaccine protects against reinfection should be targeted at COVID-19 patients before being discharged from hospital.Keywords
Full text:
Available
Collection:
Databases of international organizations
Database:
WHOIRIS
/
WHOLIS
Main subject:
Saudi Arabia
/
Disease Outbreaks
/
Cross-Sectional Studies
/
Vaccination
/
Pandemics
/
Betacoronavirus
/
COVID-19 Vaccines
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
/
Vaccines
Country/Region as subject:
Asia
Language:
English
Journal:
East. Mediterr. health j
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS